Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1856 (LINC01856) is a human gene encoding a long intergenic non-coding RNA. LINC01856 is part of the lincRNA family, whose members function primarily in the regulation of gene expression and epigenetic modifications rather than encoding proteins[1][5]. LincRNAs, including LINC01856, may modulate chromatin structure, RNA stability, and transcription regulation through mechanisms that are often highly tissue-specific[5][7]. Many lincRNAs are implicated in disease by influencing oncogenes, tumor suppressor genes, and various cellular processes, but LINC01856 itself has not been linked to any specific biological pathway, disease state, or therapeutic intervention in current genomic databases or functional studies[1][5]. As such, it is not currently a recognized therapeutic target, biomarker, or a subject of drug discovery efforts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1856 (LINC01856).